Ergoteles’s Confluent CFLT Stock Holding History

Ergoteles’s Portfolio CFLT Stock Details CFLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,384	Closed	-$579K	–	181
2023 Q2	$579K	Buy	+16,384	New	+$458K	0.03%	608

Other funds holding CFLT

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Ergoteles's CFLT Position: Q3 2023 in Review

Ergoteles sold out of Confluent (CFLT) in Q3 2023, closing a stake of 16,384 shares — an estimated $579K sold.

Ergoteles first reported a position in CFLT in Q2 2023 and held it in 1 quarter. The position peaked at $579K in Q2 2023. 345 funds tracked by Wall St. Rank hold CFLT as of Q3 2023.

Ergoteles reported no remaining Confluent position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 16,384 Confluent shares in Q3 2023, an estimated $579K.
Ergoteles first reported a position in Confluent in Q2 2023 and held it in 1 quarter.
Ergoteles's Confluent position peaked at $579K in Q2 2023.
345 funds tracked by Wall St. Rank held Confluent as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.